Wave Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
WAVE Life Sciences (WVE) PT Lowered to $6 at Stifel
May 14, 2021 8:47 AM EDTStifel analyst Paul Matteis lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $6.00 (from $7.00) while maintaining a Hold rating.
The analyst commented, "We are reiterating our Hold rating on Wave after a 1Q21 print that was punctuated by the... More
WAVE Life Sciences (WVE) Misses Q1 EPS by 27c
May 13, 2021 7:34 AM EDTWAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.86), $0.27 worse than the analyst estimate of ($0.59).
Despite our PRECISION-HD results at the end of the first quarter, it has been a productive start of the year for Wave and our team remains focused on advancing our clinical trials for... More
